Selected research
Market Structure
Global Kidney Transplant Medicine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Kidney Transplant Medicine market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for Kidney Transplant Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Kidney Transplant Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Kidney Transplant Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Kidney Transplant Medicine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Kidney Transplant Medicine include Sanofi, Novartis, Pfizer, GlaxoSmithKline plc, Veloxis Pharmaceuticals, Roche Pharmaceuticals, Prometheus Laboratories, Mayne Pharma Group Limited and Hansa Biopharma, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global Kidney Transplant Medicine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Kidney Transplant Medicine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Kidney Transplant Medicine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Kidney Transplant Medicine market size, projected growth trends, production technologies, key applications, and end-use industries.
Kidney Transplant Medicine Segment by Company
Sanofi
Novartis
Pfizer
GlaxoSmithKline plc
Veloxis Pharmaceuticals
Roche Pharmaceuticals
Prometheus Laboratories
Mayne Pharma Group Limited
Hansa Biopharma
BHARAT SERUM
Astellas Pharma
Kidney Transplant Medicine Segment by Type
Tacrolimus
Mycophenolate
Azathioprine
Ciclosporin
Other
Kidney Transplant Medicine Segment by Application
Online Sales
Offline Sales
Kidney Transplant Medicine Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Kidney Transplant Medicine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Kidney Transplant Medicine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Kidney Transplant Medicine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Kidney Transplant Medicine market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Kidney Transplant Medicine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Kidney Transplant Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Kidney Transplant Medicine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Tacrolimus
- Mycophenolate
- Azathioprine
- Ciclosporin
- Other
Applications
- Online Sales
- Offline Sales
Companies covered
- Sanofi
- Novartis
- Pfizer
- GlaxoSmithKline plc
- Veloxis Pharmaceuticals
- Roche Pharmaceuticals
- Prometheus Laboratories
- Mayne Pharma Group Limited
- Hansa Biopharma
- BHARAT SERUM
- Astellas Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Kidney Transplant Medicine Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Kidney Transplant Medicine Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Kidney Transplant Medicine Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Kidney Transplant Medicine Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Kidney Transplant Medicine Market Dynamics
- 2.1 Kidney Transplant Medicine Industry Trends
- 2.2 Kidney Transplant Medicine Industry Drivers
- 2.3 Kidney Transplant Medicine Industry Opportunities and Challenges
- 2.4 Kidney Transplant Medicine Industry Restraints
3 Kidney Transplant Medicine Market by Manufacturers
- 3.1 Global Kidney Transplant Medicine Revenue by Manufacturers (2021-2026)
- 3.2 Global Kidney Transplant Medicine Sales by Manufacturers (2021-2026)
- 3.3 Global Kidney Transplant Medicine Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Kidney Transplant Medicine Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Kidney Transplant Medicine Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Kidney Transplant Medicine Manufacturers, Product Type & Application
- 3.7 Global Kidney Transplant Medicine Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Kidney Transplant Medicine Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Kidney Transplant Medicine Players Market Share by Revenue in 2025
- 3.8.3 2025 Kidney Transplant Medicine Tier 1, Tier 2, and Tier 3
4 Kidney Transplant Medicine Market by Type
- 4.1 Kidney Transplant Medicine Type Introduction
- 4.1.1 Tacrolimus
- 4.1.2 Mycophenolate
- 4.1.3 Azathioprine
- 4.1.4 Ciclosporin
- 4.1.5 Other
- 4.2 Global Kidney Transplant Medicine Sales by Type
- 4.2.1 Global Kidney Transplant Medicine Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Kidney Transplant Medicine Sales by Type (2021-2032)
- 4.2.3 Global Kidney Transplant Medicine Sales Market Share by Type (2021-2032)
- 4.3 Global Kidney Transplant Medicine Revenue by Type
- 4.3.1 Global Kidney Transplant Medicine Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Kidney Transplant Medicine Revenue by Type (2021-2032)
- 4.3.3 Global Kidney Transplant Medicine Revenue Market Share by Type (2021-2032)
5 Kidney Transplant Medicine Market by Application
- 5.1 Kidney Transplant Medicine Application Introduction
- 5.1.1 Online Sales
- 5.1.2 Offline Sales
- 5.2 Global Kidney Transplant Medicine Sales by Application
- 5.2.1 Global Kidney Transplant Medicine Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Kidney Transplant Medicine Sales by Application (2021-2032)
- 5.2.3 Global Kidney Transplant Medicine Sales Market Share by Application (2021-2032)
- 5.3 Global Kidney Transplant Medicine Revenue by Application
- 5.3.1 Global Kidney Transplant Medicine Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Kidney Transplant Medicine Revenue by Application (2021-2032)
- 5.3.3 Global Kidney Transplant Medicine Revenue Market Share by Application (2021-2032)
6 Global Kidney Transplant Medicine Sales by Region
- 6.1 Global Kidney Transplant Medicine Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Kidney Transplant Medicine Sales by Region (2021-2032)
- 6.2.1 Global Kidney Transplant Medicine Sales by Region (2021-2026)
- 6.2.2 Global Kidney Transplant Medicine Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Kidney Transplant Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Kidney Transplant Medicine Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Kidney Transplant Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Kidney Transplant Medicine Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Kidney Transplant Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Kidney Transplant Medicine Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Kidney Transplant Medicine Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Kidney Transplant Medicine Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Kidney Transplant Medicine Revenue by Region
- 7.1 Global Kidney Transplant Medicine Revenue by Region
- 7.1.1 Global Kidney Transplant Medicine Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Kidney Transplant Medicine Revenue by Region (2021-2026)
- 7.1.3 Global Kidney Transplant Medicine Revenue by Region (2027-2032)
- 7.1.4 Global Kidney Transplant Medicine Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Kidney Transplant Medicine Revenue (2021-2032)
- 7.2.2 North America Kidney Transplant Medicine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Kidney Transplant Medicine Revenue (2021-2032)
- 7.3.2 Europe Kidney Transplant Medicine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Kidney Transplant Medicine Revenue (2021-2032)
- 7.4.2 Asia-Pacific Kidney Transplant Medicine Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Kidney Transplant Medicine Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Kidney Transplant Medicine Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Sanofi
- 8.1.1 Sanofi Company Information
- 8.1.2 Sanofi Business Overview
- 8.1.3 Sanofi Kidney Transplant Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Sanofi Kidney Transplant Medicine Product Portfolio
- 8.1.5 Sanofi Recent Developments
- 8.2 Novartis
- 8.2.1 Novartis Company Information
- 8.2.2 Novartis Business Overview
- 8.2.3 Novartis Kidney Transplant Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Novartis Kidney Transplant Medicine Product Portfolio
- 8.2.5 Novartis Recent Developments
- 8.3 Pfizer
- 8.3.1 Pfizer Company Information
- 8.3.2 Pfizer Business Overview
- 8.3.3 Pfizer Kidney Transplant Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Pfizer Kidney Transplant Medicine Product Portfolio
- 8.3.5 Pfizer Recent Developments
- 8.4 GlaxoSmithKline plc
- 8.4.1 GlaxoSmithKline plc Company Information
- 8.4.2 GlaxoSmithKline plc Business Overview
- 8.4.3 GlaxoSmithKline plc Kidney Transplant Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 GlaxoSmithKline plc Kidney Transplant Medicine Product Portfolio
- 8.4.5 GlaxoSmithKline plc Recent Developments
- 8.5 Veloxis Pharmaceuticals
- 8.5.1 Veloxis Pharmaceuticals Company Information
- 8.5.2 Veloxis Pharmaceuticals Business Overview
- 8.5.3 Veloxis Pharmaceuticals Kidney Transplant Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Veloxis Pharmaceuticals Kidney Transplant Medicine Product Portfolio
- 8.5.5 Veloxis Pharmaceuticals Recent Developments
- 8.6 Roche Pharmaceuticals
- 8.6.1 Roche Pharmaceuticals Company Information
- 8.6.2 Roche Pharmaceuticals Business Overview
- 8.6.3 Roche Pharmaceuticals Kidney Transplant Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Roche Pharmaceuticals Kidney Transplant Medicine Product Portfolio
- 8.6.5 Roche Pharmaceuticals Recent Developments
- 8.7 Prometheus Laboratories
- 8.7.1 Prometheus Laboratories Company Information
- 8.7.2 Prometheus Laboratories Business Overview
- 8.7.3 Prometheus Laboratories Kidney Transplant Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Prometheus Laboratories Kidney Transplant Medicine Product Portfolio
- 8.7.5 Prometheus Laboratories Recent Developments
- 8.8 Mayne Pharma Group Limited
- 8.8.1 Mayne Pharma Group Limited Company Information
- 8.8.2 Mayne Pharma Group Limited Business Overview
- 8.8.3 Mayne Pharma Group Limited Kidney Transplant Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Mayne Pharma Group Limited Kidney Transplant Medicine Product Portfolio
- 8.8.5 Mayne Pharma Group Limited Recent Developments
- 8.9 Hansa Biopharma
- 8.9.1 Hansa Biopharma Company Information
- 8.9.2 Hansa Biopharma Business Overview
- 8.9.3 Hansa Biopharma Kidney Transplant Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Hansa Biopharma Kidney Transplant Medicine Product Portfolio
- 8.9.5 Hansa Biopharma Recent Developments
- 8.10 BHARAT SERUM
- 8.10.1 BHARAT SERUM Company Information
- 8.10.2 BHARAT SERUM Business Overview
- 8.10.3 BHARAT SERUM Kidney Transplant Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 BHARAT SERUM Kidney Transplant Medicine Product Portfolio
- 8.10.5 BHARAT SERUM Recent Developments
- 8.11 Astellas Pharma
- 8.11.1 Astellas Pharma Company Information
- 8.11.2 Astellas Pharma Business Overview
- 8.11.3 Astellas Pharma Kidney Transplant Medicine Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Astellas Pharma Kidney Transplant Medicine Product Portfolio
- 8.11.5 Astellas Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Kidney Transplant Medicine Value Chain Analysis
- 9.1.1 Kidney Transplant Medicine Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Kidney Transplant Medicine Production Mode & Process
- 9.2 Kidney Transplant Medicine Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Kidney Transplant Medicine Distributors
- 9.2.3 Kidney Transplant Medicine Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst